AMOÉBA Lyon, Castello d'Argile, 5th January 2017 - AMOEBA (FR0011051598 - AMEBA), the producer of a biological biocide capable of eliminating the risk of waterborne bacteria, announced today that it has signed a Letter of Intent (LOI) with NCR Biochemical prior to entering into a definitive agreement regarding the distribution of its BIOMEBA product in Italy. This agreement is subject to marketing authorization (MA) that may happen during the first semester of 2017.
This new LOI follows the agreement signed at the end of 2015 with the company DREWO and strengthens the position of AMOEBA in Italy. The partnership with NCR Biochemical enables AMOEBA to extend the distribution of its BIOMEBA product for the treatment of cooling towers in the industrial and tertiary markets.
AMOEBA now counts a total of 12 distributors spread over the European and American continents.
«Thanks to the signature of this agreement, we are moving steps towards the future of water treatment. Environment protection and biotechnologies are the key to reach a sustainable development and we share this vision with AMOEBA. » stated Marco NOVI, Managing Director General of NCR Biochemical.
« This new agreement with NCR Biochemical strengthens our commercial presence in Italy and naturally enhance the commercial network already in place.» added Fabrice PLASSON, President of the Board of AMOEBA.
About NCR Biochemical: We are an international chemical company specialized in water treatments, biotechnologies and process additives for the paper and sugar industries. The headquarter is based in Bologna area and three more subsidiaries are located in Milan area, Saint Petersburg (Russia) and Shenzhen (China). We produce innovative technologies, find the best solutions for our customers, develop our own dosing systems and have thirty years' experience in pursuing quality, safety and environmental responsibility. We are constantly looking for improved solutions in order to optimize energy use and achieve the best operational and profit performance for our customers. With a large staff of chemists and biologists, field technicians, engineers, product managers, two chemical laboratories, a papermaking workshop, a biological laboratory, a technological laboratory, we are a leading company on water treatments in Italy. For more information:www.ncr-biochemical.com
About AMOEBA: AMOEBA develops a biological biocide capable of eliminating waterborne bacterial risk (legionella, pseudomonas, listeria, etc.). This entirely natural solution is presented as an alternative to the chemical treatments traditionally used in the industrial sector and complies with the new regulations in terms of chemical emissions into the environment. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today concentrating on the segment of industrial air-cooled towers (ACT), estimated to be worth EUR 1.7bn (2). AMOEBA is pursuing the regulatory procedures to obtain the provisional MA for all European countries in "Cooling Towers" application. Based in Chassieu - France. AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index. For more information: www.amoeba-biocide.com.
: Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets
: Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Contacts :
Amoeba Nathalie COMBROUSSE Marketing Communication Manager +33 (0)4 81 09 18 15 nathalie.combrousse@amoeba-biocide.com | Actifin Ghislaine GASPARETTO Financial Communication +33(0)1 56 88 11 11 ggasparetto@actifin.fr |
Amoéba Biocide SA published this content on 05 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2017 17:02:08 UTC.
Original documenthttp://www.amoeba-biocide.com/sites/default/files/170105_amoeba_-_loi_ncr_en.pdf
Public permalinkhttp://www.publicnow.com/view/0CCF2467104EEC25A814CAF5085CE225FAFED204
